ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KYMR Kymera Therapeutics Inc

31.20
-0.62 (-1.95%)
Last Updated: 12:33:16
Delayed by 15 minutes

Period:

Draw Mode:

Volume 177,295
Bid Price 31.19
Ask Price 31.28
News -
Day High 31.89

Low
9.60

52 Week Range

High
45.31

Day Low 30.77
Company Name Stock Ticker Symbol Market Type
Kymera Therapeutics Inc KYMR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.62 -1.95% 31.20 12:33:16
Open Price Low Price High Price Close Price Prev Close
31.70 30.77 31.89 31.82
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,081 177,295 $ 31.13 $ 5,518,697 - 9.60 - 45.31
Last Trade Time Type Quantity Stock Price Currency
12:33:21 19 $ 31.245 USD

Kymera Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.89B 61.11M - 78.59M -146.96M -2.40 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Kymera Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KYMR Message Board. Create One! See More Posts on KYMR Message Board See More Message Board Posts

Historical KYMR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.9436.6230.7733.58458,794-2.74-8.07%
1 Month36.0136.6230.7733.38471,240-4.81-13.36%
3 Months40.0640.6230.7735.37497,843-8.86-22.12%
6 Months25.8445.3122.3533.78689,2525.3620.74%
1 Year25.6445.319.6026.52646,7125.5621.68%
3 Years46.9069.129.6031.11583,092-15.70-33.48%
5 Years32.9291.929.6032.96515,115-1.72-5.22%

Kymera Therapeutics Description

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Your Recent History

Delayed Upgrade Clock